University of Birmingham
3 clinical trials · 3 recruiting · OTHER
Trials by University of Birmingham
RECRUITINGPhase 2NCT05629702
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
ARISTOCRAT is a phase II, multi-centre, double-blind, placebo-controlled, randomised trial to compare the cannabinoid Nabiximols with placebo in patients with recurrent MGMT...
Sponsor: University of BirminghamEnrolling: 12020 locations
GlioblastomaBrain TumorCannabis+1
RECRUITINGPhase 4NCT04700826
Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation
The DaRe2 approach (healthcare Data for pragmatic clinical Research in the NHS - primary 2 secondary) is designed to operationalise efficient, nationwide, primary care approaches...
Sponsor: University of BirminghamEnrolling: 30001 location
Atrial Fibrillation
RECRUITINGNCT07246356
Feasibility and Efficacy of GTEP for Birth Trauma
This clinical study aims to evaluate the feasibility and initial efficacy of Group Traumatic Episode Protocol (GTEP) for reducing trauma symptoms (measured by the PCL-5 and City...
Sponsor: University of BirminghamEnrolling: 101 location
PTSD (Childbirth-Related)Psychological WellbeingBonding